Palvella Therapeutics PVLA Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $206.39M+256% | $57.98M-8.8% | $63.57M-9.7% | $70.43M-6.9% | $75.63M-9.5% | ||
| $263.23M+346% | $58.99M-11.9% | $66.94M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $263.76M+343% | $59.56M-11.0% | $66.94M-9.2% | $73.75M-7.2% | $79.44M-10.0% | ||
| $5.44M+18.5% | $4.6M+32.0% | $3.48M-23.6% | $4.56M+2.6% | $4.44M-3.2% | ||
| $9.12M-19.6% | $11.34M+10.0% | $10.31M+7.2% | $9.62M+7.0% | $8.98M-25.4% | ||
| $31.45M-0.4% | $31.58M+11.8% | $28.26M— | —— | —— | ||
| $14K+16.7% | $12K+9.1% | $11K0.0% | $11K0.0% | $11K0.0% | ||
| -$151.22M-11.6% | -$135.45M-10.4% | -$122.74M-10.2% | -$111.39M-9.3% | -$101.92M-8.7% | ||
| $232.31M+730% | $27.98M-27.7% | $38.68M-19.0% | $47.78M-14.0% | $55.58M-11.2% | ||
| $263.76M+343% | $59.56M-11.0% | $66.94M-9.2% | $73.75M-7.2% | $79.44M-10.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Palvella Therapeutics cover its short-term obligations?
- Its current ratio is 28.88 — current assets exceed current liabilities.
- Where does Palvella Therapeutics's balance sheet data come from?
- Every line is extracted from Palvella Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.